Skip to main content
. 2022 Aug 30;54(8):1290–1305. doi: 10.1038/s12276-022-00837-6

Fig. 10. Schematic of e-375i elicited anti-PCa effects.

Fig. 10

Shown is the graphical illustration of the identified pathway of miR-375 in regulating PCa progression and enzalutamide resistance.